A New Treatment for Acid Sphingomyelinase Deficiency Could be Approved in the EU Soon
source: pixabay.com

A New Treatment for Acid Sphingomyelinase Deficiency Could be Approved in the EU Soon

According to a story from Globe Newswire, The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recently announced a positive opinion in regards to the experimental…

Continue Reading A New Treatment for Acid Sphingomyelinase Deficiency Could be Approved in the EU Soon
Amyotrophic Lateral Sclerosis Patients Have an Alternative to Radicava ORS via IV
qimono / Pixabay

Amyotrophic Lateral Sclerosis Patients Have an Alternative to Radicava ORS via IV

The new FDA-approved oral formulation of  Radicava ORS (edaravone) is more convenient than the intravenous formulation, yet the efficacy and composition remain the same. The oral formulation may also be…

Continue Reading Amyotrophic Lateral Sclerosis Patients Have an Alternative to Radicava ORS via IV

Patient Story: Breaking the Stereotypes Around ME

According to a recent article, 82-year-old Veronica Jones is working to break the laziness stigma that surrounds a myalgic encephalomyelitis diagnosis. Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) Myalgic encephalomyelitis (ME),…

Continue Reading Patient Story: Breaking the Stereotypes Around ME

Study: Eosinophilic Esophagitis Patients at Greater Risk for Psychiatric Illness

A recent study published in the American Journal of Gastroenterology has demonstrated that people diagnosed with eosinophilic esophagitis (EoE) are at a higher risk for anxiety, mood disorders, as well as ADHD. With this…

Continue Reading Study: Eosinophilic Esophagitis Patients at Greater Risk for Psychiatric Illness
High Rate of Bone Problems in Female Hemophilia Carriers
https://pixabay.com/en/skeleton-hand-bones-anatomy-joint-778069/

High Rate of Bone Problems in Female Hemophilia Carriers

In the past, researchers have observed a relationship between hemophilia and bone-related issues. However, while this observation is helpful, there have been few studies examining the prevalence of bone problems…

Continue Reading High Rate of Bone Problems in Female Hemophilia Carriers
ICYMI: EDSIVO for vEDS Earns Breakthrough Therapy Designation
stevepb / Pixabay

ICYMI: EDSIVO for vEDS Earns Breakthrough Therapy Designation

In the United States, the FDA grants Breakthrough Therapy designation to drugs intended to treat serious and life-threatening illnesses, and/or drugs which show significant improvement over available therapies. After receiving…

Continue Reading ICYMI: EDSIVO for vEDS Earns Breakthrough Therapy Designation

Editor’s Choice: Developments In Beta Thalassemia, Eosinophilic Esophagitis and Congenital Adrenal Hyperplasia

Happy Friday! This week, we have details on an investigational compound for beta thalassemia. Also, we break down the details of a new study that examines psychiatric illness rates among…

Continue Reading Editor’s Choice: Developments In Beta Thalassemia, Eosinophilic Esophagitis and Congenital Adrenal Hyperplasia